Elevance Health Overview
Elevance Health Target Price
Analysts' average 12-month price target for Elevance Health is $440.
Get informed when a big investor buys or sells
+ FollowShare Price
$390.24
Average Target Price
$439.76
12.7% upside
12.7% upside25 analysts in the last 4 months
High: $498 | Low: $331
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-17 | Leerink Partners | $395 | 1.2% upside |  |
| 2026-07-16 | Bernstein | $488 | 25.1% upside | |
| 2026-07-16 | Barclays | $457 | 17.1% upside | |
| 2026-07-16 | Wells FargoStephen Baxter | $473 | 21.2% upside | |
| 2026-07-16 | Guggenheim | $455 | 16.6% upside | |
| 2026-07-16 | Robert W. Baird | $393 | 0.7% upside | |
| 2026-07-16 | Goldman Sachs | $395 | 1.2% upside | |
| 2026-07-16 | RBC Capital | $424 | 8.7% upside | |
| 2026-07-16 | New Street | $482 | 23.5% upside | |
| 2026-07-14 | Truist Financial | $475 | 21.7% upside | |
| 2026-07-13 | Wells Fargo | $492 | 26.1% upside | |
| 2026-07-09 | RBC CapitalBen Hendrix | $439 | 12.5% upside | |
| 2026-07-07 | Raymond JamesSarah James | $450 | 15.3% upside | |
| 2026-07-02 | Bernstein | $482 | 23.5% upside | |
| 2026-06-08 | Mizuho Securities | $465 | 19.2% upside | |
| 2026-06-04 | Morgan Stanley | $404 | 3.5% upside | |
| 2026-06-01 | Truist FinancialDavid MacDonald | $450 | 15.3% upside | |
| 2026-05-26 | BarclaysAndrew Mok | $480 | 23% upside | |
| 2026-05-22 | UBS | $460 | 17.9% upside | |
| 2026-05-20 | Deutsche Bank | $498 | 27.6% upside | |
| 2026-05-20 | Mizuho Securities | $435 | 11.5% upside | |
| 2026-04-24 | Barclays | $408 | 4.6% upside | |
| 2026-04-24 | Guggenheim | $399 | 2.2% upside | |
| 2026-04-23 | Leerink Partners | $364 |  6.7% downside | |
| 2026-04-23 | Robert W. Baird | $331 | 15.2% downside | |
| 2026-04-20 | JefferiesDavid Windley | $391 | 0.2% upside | |
| 2026-03-10 | Mizuho SecuritiesAnn Hynes | $350 | 10.3% downside | |
| 2026-02-03 | RBC Capital | $358 | 8.3% downside | |
| 2026-02-02 | Truist Financial | $390 | 0.1% downside | |
| 2026-02-02 | Piper Sandler | $409 | 4.8% upside | |
| 2026-02-02 | Craig-Hallum | $409 | 4.8% upside | |
| 2026-02-01 | Bernstein | $409 | 4.8% upside | |
| 2026-01-30 | Wells Fargo | $391 | 0.2% upside | |
| 2026-01-30 | Barclays | $393 | 0.7% upside | |
| 2026-01-29 | UBS | $400 | 2.5% upside | |
| 2026-01-29 | Deutsche Bank | $332 | 14.9% downside | |
| 2026-01-29 | GuggenheimJason Cassorla | $396 | 1.5% upside | |
| 2026-01-22 | GuggenheimJason Cassorla | $414 | 6.1% upside | |
| 2026-01-09 | Mizuho SecuritiesAnn Hynes | $413 | 5.8% upside | |
| 2026-01-08 | Wolfe ResearchJustin Lake | $425 | 8.9% upside | |
| 2026-01-07 | Wells Fargo | $424 | 8.7% upside | |
| 2026-01-06 | Bernstein | $431 | 10.4% upside | |
| 2026-01-05 | BarclaysAndrew Mok | $404 | 3.5% upside | |
| 2025-12-19 | Deutsche BankGeorge Hill | $320 | 18% downside | |
| 2025-12-18 | Morgan Stanley | $352 | 9.8% downside | |
| 2025-11-03 | Mizuho Securities | $400 | 2.5% upside | |
| 2025-10-22 | Barclays | $385 | 1.3% downside | |
| 2025-10-21 | Bernstein | $420 | 7.6% upside | |
| 2025-10-14 | Goldman Sachs | $343 | 12.1% downside | |
| 2025-10-14 | Truist Financial | $400 | 2.5% upside | |